Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery Platform
Sponsor : AbCellera
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Under the terms of the asset purchase agreement, AbCellera acquires full rights to the OrthoMab platform and Dualogics retains rights to develop existing internal assets and to complete existing partnership programs.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
August 20, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery Platform
Sponsor : AbCellera
Deal Size : Undisclosed
Deal Type : Acquisition